RU 24969
Modify Date: 2024-01-09 16:55:57
RU 24969 structure
|
Common Name | RU 24969 | ||
|---|---|---|---|---|
| CAS Number | 66611-26-5 | Molecular Weight | 228.29000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C14H16N2O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of RU 24969RU 24969 is a selective agonist at the 5-HT1A and 5-HT1B receptors; IC50 value:Target: 5-HT1A/1B agonistRU 24969 possesses preference for the purported 5-HT1B subtype of central 5-HT1 recognition site. The reported significant linear correlation between hypotensive activity following intravenous (i.v.) administration to anesthetized rats and affinity for the central 5-HT1 binding site could only be maintained by incorporation of the affinity of RU 24969 for its low and 8-OH-DPAT for its high affinity binding site [1]. The drug RU 24969 (10 mg/kg) inhibited the rate of synthesis of 5-HT in rat brain by about 50%. Pretreatment of rats with desmethylimipramine over a longer term or clenbuterol given acutely, treatments known to enhance the behavioural responses of rats to various other 5-HT agonists, did not alter the RU 24969-induced response [2]. RU 24969 (0.03-3.0mg/kg, s.c.) dose-dependently decreased water consumption in water deprived rats [3]. |
| Name | 5-methoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole |
|---|---|
| Synonym | More Synonyms |
| Description | RU 24969 is a selective agonist at the 5-HT1A and 5-HT1B receptors; IC50 value:Target: 5-HT1A/1B agonistRU 24969 possesses preference for the purported 5-HT1B subtype of central 5-HT1 recognition site. The reported significant linear correlation between hypotensive activity following intravenous (i.v.) administration to anesthetized rats and affinity for the central 5-HT1 binding site could only be maintained by incorporation of the affinity of RU 24969 for its low and 8-OH-DPAT for its high affinity binding site [1]. The drug RU 24969 (10 mg/kg) inhibited the rate of synthesis of 5-HT in rat brain by about 50%. Pretreatment of rats with desmethylimipramine over a longer term or clenbuterol given acutely, treatments known to enhance the behavioural responses of rats to various other 5-HT agonists, did not alter the RU 24969-induced response [2]. RU 24969 (0.03-3.0mg/kg, s.c.) dose-dependently decreased water consumption in water deprived rats [3]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C14H16N2O |
|---|---|
| Molecular Weight | 228.29000 |
| Exact Mass | 228.12600 |
| PSA | 37.05000 |
| LogP | 2.88200 |
| Storage condition | 2-8℃ |
| HS Code | 2933990090 |
|---|
|
~88%
RU 24969 CAS#:66611-26-5 |
| Literature: BIO-MEDISINSK INNOVASJON AS; COCKBAIN, Julian Patent: WO2007/7072 A1, 2007 ; Location in patent: Page/Page column 21-22 ; WO 2007/007072 A1 |
|
~%
RU 24969 CAS#:66611-26-5 |
| Literature: Eli Lilly and Company Patent: US5614523 A1, 1997 ; US 5614523 A |
|
~%
RU 24969 CAS#:66611-26-5 |
| Literature: Eli Lilly and Company Patent: US5846982 A1, 1998 ; US 5846982 A |
|
~%
RU 24969 CAS#:66611-26-5 |
| Literature: Mattsson, Cecilia; Sonesson, Clas; Sandahl, Anna; Greiner, Hartmut E.; Gassen, Michael; Plaschke, Joerg; Leibrock, Joachim; Boettcher, Henning Bioorganic and Medicinal Chemistry Letters, 2005 , vol. 15, # 19 p. 4230 - 4234 |
CAS#:52157-82-1| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| Tocris-0912 |
| RU 24969 |